| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.097 | 0.006 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.097 | 0.007 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.007 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.15 | 0.007 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.008 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.009 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.12 | 0.009 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.009 |